<span class="vcard">John Joseph</span>
John Joseph

Fetal inflammatory response severity on placental histology identifies neonates at risk for meconium aspiration syndrome

Pediatr Res. 2025 Dec 4. doi: 10.1038/s41390-025-04657-y. Online ahead of print. ABSTRACT BACKGROUND: While fetal hypoxia-ischemia is a known trigger for meconium aspiration syndrome (MAS), …

Mixed-methods evaluation protocol for the Nurturing Connections Programme: a new Australian perinatal and infant mental health service

BMJ Open. 2025 Dec 4;15(12):e108094. doi: 10.1136/bmjopen-2025-108094. ABSTRACT INTRODUCTION: Forming secure attachment relationships provides children with the best possible start to life. Children from families …

HERNIIA-II trial (Hernia Endoscopic oR opeN repair In chIldren Analysis): a protocol of a multicentre randomised controlled trial to study the (cost-)effectiveness of laparoscopic hernia repair compared to open hernia repair in children 0-16 years

BMJ Open. 2025 Dec 4;15(12):e110662. doi: 10.1136/bmjopen-2025-110662. ABSTRACT INTRODUCTION: Inguinal hernia repair is one of the most frequently performed operations in the paediatric population and …

The Association Between Traffic-Related Air Pollution and risk of Non-reassuring Fetal Heart Rate in Newborns at Birth

Environ Res. 2025 Dec 2:123499. doi: 10.1016/j.envres.2025.123499. Online ahead of print. ABSTRACT Despite the biological plausibility linking traffic-related air pollution (TRAP) to adverse intrapartum outcomes, …

The triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents

Eur J Pediatr. 2025 Dec 5;184(12):820. doi: 10.1007/s00431-025-06632-5. ABSTRACT The triglyceride/glucose index (TyG index), a formula derived from fasting triglyceride (TG) and glucose levels, has …

Siltuximab monotherapy improves progression free survival compared to rituximab-based therapies in patients with idiopathic multicentric Castleman disease; indirect comparison of studies using single-arm metanalysis method and the generalized linear mixed model

Ann Hematol. 2025 Dec 5. doi: 10.1007/s00277-025-06560-2. Online ahead of print. ABSTRACT Siltuximab is the only approved treatment for idiopathic multicentric Castleman Disease but in …